RxDoctor Payments Data

Kelley Pruiett

Nurse Practitioner · Perrysburg, OHNPI 1649583139

Payments from drug & device makers

$4,719in general payments, 2019–2025

Across 142 payments — averaging $33.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • AstraZeneca$391
  • Novartis$362
  • E.r. Squibb & Sons, L.L.C.$319
  • Scpharmaceuticals Inc.$283
  • Merck$250
  • plus $2K from 18 others

What the payments were for

  • Travel & lodging$1,06523%
  • Food & beverage$3,65477%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,719 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$69,490
Medicare patients
503
Services billed
1,008

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban672$612,866
EntrestoSacubitril/Valsartan164$154,012
XareltoRivaroxaban115$151,850
FarxigaDapagliflozin Propanediol91$86,414
Repatha SureclickEvolocumab109$84,140
JardianceEmpagliflozin26$27,729
VascepaIcosapent Ethyl65$24,857
Praluent PenAlirocumab43$22,130
MultaqDronedarone Hcl11$18,209
Metoprolol Succinate923$15,028
CorlanorIvabradine Hcl17$12,112
Icosapent Ethyl26$10,547
Atorvastatin Calcium789$9,310
BrilintaTicagrelor11$8,997
Ranolazine ErRanolazine54$6,804

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$107$612,866672 claims
NovartisEntresto$362$154,012164 claims
Johnson & JohnsonXarelto$202$151,850115 claims
AstraZenecaFarxiga, Brilinta$391$95,411102 claims
Boehringer IngelheimJardiance$58$27,72926 claims
Sanofi-aventis U.S. LLCMultaq$22$18,20911 claims
AmgenCorlanor$30$12,11217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Perrysburg

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →